Mitomycin- Pharmacology: An antibacterial drug, which inhibits the synthesis of DNA.
Indication: Alleviating treatment of disseminated glandular cancer of stomach and pancreas.
Colorectal, breast cancer, bladder, squamous cell cancer of head and neck, lungs, cervix; conjunctiva.
Mitomycin is an anticancer medication that interferes with the maturation of cancer cells and slows down their growth and outspread in the body. It is utilized to treat the cancer of the pancreas and stomach. It can also be employed for the purposes, which are not mentioned.
Mitomycin (TN) is one of the old chemotherapy medicates, which has been in use for decenniums. It is an antibacterial drug that has been shown to have anti-tumor activity and inhibits the synthesis of deoxyribonucleic acid (DNA). The cytosine and guanine content correlates with the grade of mitomycin-induced cross-linking. At high properties of the medicate, protein synthesis and cellular RNA are also inhibited. Mitomycin (TN) has been indicated in vitro to suppress T cell, B cell and macrophage maturation and damage antigen presentation and the secretion of TNFa, interferon gamma and IL-2.
Indication: For the treatment of cancerous neoplasm of oral cavity, lip, digestive organs, peritoneum, female breast, pharynx and urinary bladder.
Intravenous Solid tumors of the breast, cervix, eye, bladder, liver, lung, stomach and endocrine gland.